Several US hospitals using hydroxychloroquine in treatment of COVID 19 patients: Report
4 years, 8 months ago

Several US hospitals using hydroxychloroquine in treatment of COVID 19 patients: Report

India TV News  

Several hospitals in the United States continue to use malaria drug hydroxychloroquine in the treatment of COVID-19 positive patients, a media report said. Medical publication, MDedge on Friday reported that hydroxychloroquine, the malaria drug, is currently the first-line therapy and Tocilizumab the second-line medication for people hospitalized with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals across Connecticut. “Hydroxychloroquine is first-line at Yale because in-vitro data shows potent inhibition of the virus and possible clinical benefit, which is about as good as evidence gets at the moment,” Indian American cardiologist Nihar Desai told the medical publication. On Friday, US Food and Drug Administration gave emergency use authorization for the use of investigational anti-viral Remdesivir for the treatment of COVID 19 patients.

Patients Report Covid Hydroxychloroquine Hcq Covid 19 Patients  patients  hydroxychloroquine  hospitals  covid19  19  united  treatment  drug  yale  malaria  virus  covid  using  report

History of this topic

"Hundreds" of Dutch died from hydroxychloroquine side effects during Covid pandemic
1 year ago

"Hundreds" of Dutch died from hydroxychloroquine side effects during Covid pandemic

NL Times  

In the early phase of the coronavirus pandemic, several hundred Dutch people died from the side effects of hydroxychloroquine, the malaria drug that seemed promising against COVID-19. And laboratory research showed that this drug might work.” Of the COVID-19 patients treated in Dutch hospitals, an estimated 10,000 or so were given hydroxychloroquine, and about 2,000 ultimately died, Bonten said. “If …

Posts mislead on Mayo Clinic’s hydroxychloroquine webpage
55 years ago

Posts mislead on Mayo Clinic’s hydroxychloroquine webpage

Associated Press  

CLAIM: The Mayo Clinic “quietly” updated its website in 2023 to say that hydroxychloroquine can now be used to treat COVID-19. A page about hydroxychloroquine on the hospital system’s website included outdated guidance that the malaria drug “may also be used to treat coronavirus in certain hospitalized patients.” But archives show the text has been there since at least May …

COVID treatments weren’t suppressed to OK vaccines’ emergency use
55 years ago

COVID treatments weren’t suppressed to OK vaccines’ emergency use

Associated Press  

CLAIM: Ivermectin and hydroxychloroquine were suppressed as COVID-19 treatments because the vaccines couldn’t receive emergency use authorization if such treatments were available. THE FACTS: Social media users are sharing a conspiracy theory that posits that the drugs hydroxychloroquine and ivermectin were withheld as COVID-19 treatments by officials in order to greenlight vaccines under emergency use authorization. An emergency use authorization, …

Panel: Trump staffers pushed unproven COVID treatment at FDA
2 years, 4 months ago

Panel: Trump staffers pushed unproven COVID treatment at FDA

Associated Press  

WASHINGTON — Officials in the Trump White House tried to pressure U.S. health experts into reauthorizing a discredited COVID-19 treatment, according to a congressional investigation that provides new evidence of that administration’s efforts to override Food and Drug Administration decisions early in the pandemic. But Hahn told investigators that he felt pressure due to the “persistence” of Trump aide Peter …

Oral pill for COVID-19 approved by regulator
2 years, 5 months ago

Oral pill for COVID-19 approved by regulator

China Daily  

China Daily| Updated :2022-07-29 China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus. Azvudine, developed by the Genuine Biotech Co based in Henan province, was first conditionally approved to treat HIV-1 infected adult patients …

WHO recommends Pfizer's pill Paxlovid for mild Covid cases
2 years, 8 months ago

WHO recommends Pfizer's pill Paxlovid for mild Covid cases

India Today  

The World Health Organisation has strongly recommended nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate Covid-19 patients at highest risk of hospital admission. Pfizer’s oral antiviral drug is strongly recommended for patients with non-severe Covid-19 who are at highest risk of developing severe disease and hospitalisation, such as unvaccinated, older, or immunosuppressed patients. The global health …

WHO adds new drugs to COVID treatments amid Omicron surge
2 years, 11 months ago

WHO adds new drugs to COVID treatments amid Omicron surge

Al Jazeera  

Latest recommendations prompt new calls for patent waivers to allow more people access to treatments. The drug baricitinib, which is also used to treat rheumatoid arthritis, is “strongly recommended” for patients with severe or critical COVID-19, in combination with corticosteroids, the UN agency’s panel of international experts said in the guidelines which were published by the British Medical Journal on …

Have Covid-19 And In Home Isolation? Govt Advises On Medicines To Be Taken
2 years, 11 months ago

Have Covid-19 And In Home Isolation? Govt Advises On Medicines To Be Taken

ABP News  

New Delhi: The government expressed concern over "misuse and overuse" of Covid-19 drugs as cases continue to spike in India driven by the highly transmissible Omicron variant. Addressing a press conference, NITI Aayog Member Dr VK Paul said Covid-19 patients in home isolation should take paracetamol for fever and for cough, Ayush syrup could be used. Dr VK Paul said …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

Online doctors giving ivermectin to Covid patients; Investigation launched
3 years ago

Online doctors giving ivermectin to Covid patients; Investigation launched

NL Times  

The Health and Youth Care Inspectorate is investigating a group of doctors who prescribed the controversial drug Ivermectin to people with Covid-19. The Inspectorate said it will tackle doctors and pharmacists who still provide the drug to patients with the coronavirus. Despite the lack of scientific evidence for the effect of Ivermectin against Covid-19, the drug is still recommended on …

What you should know about treating Covid-19
3 years, 1 month ago

What you should know about treating Covid-19

Live Mint  

Within a few weeks, the US could have access to the first antiviral pills to treat Covid-19, either from Pfizer Inc. or Merck & Co. and partner Ridgeback Biotherapeutics LP. Doctors say an initial step is to monitor symptoms to determine whether infected people could be considered at low or high risk for developing severe disease. Patients who don’t respond …

Merck’s COVID-19 pill narrowly wins FDA panel’s support
3 years, 1 month ago

Merck’s COVID-19 pill narrowly wins FDA panel’s support

LA Times  

An FDA panel voted 13 to 10 to recommend authorization of Merck’s experimental COVID-19 drug, molnupiravir, on Tuesday — with many caveats. Harvard infectious disease specialist Dr. Lindsey R. Baden, who chairs the FDA advisory committee, called molnupiravir’s apparent effectiveness “wobbly.” He said his own decision to recommend that the FDA grant emergency-use authorization was “incredibly difficult” in light of …

EU regulator recommends Merck’s COVID-19 pill for emergency use
3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera  

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 2 months ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir
3 years, 2 months ago

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir

India Today  

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic. Britain's Medicines and Healthcare products Regulatory Agency recommended the drug, molnupiravir, for use in people with mild to moderate COVID-19 and at …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 2 months ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

Maryland congressman says he prescribes ivermectin for COVID
3 years, 2 months ago

Maryland congressman says he prescribes ivermectin for COVID

Associated Press  

BALTIMORE — A Maryland congressman who is a practicing anesthesiologist said on a radio show that he prescribed a medication typically used to treat parasites in livestock and humans as a treatment for COVID-19. Republican Rep. Andy Harris, who represents Maryland’s 1st District, made the comments during a call-in radio program that he and his wife, Nicole, co-hosted last month …

Merck seeks US authorisation for pill to treat COVID
3 years, 3 months ago

Merck seeks US authorisation for pill to treat COVID

Al Jazeera  

US pharmaceutical giant submits request for FDA approval for molnupiravir pill to treat mild-to-moderate COVID-19 cases. US pharmaceutical company Merck has requested emergency authorisation for its experimental pill to treat mild-to-moderate cases of COVID-19, in what would add a promising, new tool to the global fight against the virus. Merck submitted the application for molnupiravir, which it said earlier this …

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?
3 years, 3 months ago

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?

CNN  

CNN — Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19. But Merck says it will seek authorization from the US Food and Drug Administration, and if it’s granted, the drug could be the first antiviral treatment available orally to fight Covid-19. …

Why HCQ and Ivermectin were removed from India's Covid-19 treatment protocol
3 years, 3 months ago

Why HCQ and Ivermectin were removed from India's Covid-19 treatment protocol

India Today  

The Indian Council of Medical Research and the National Task Force on Covid-19 have dropped the use of Ivermectin and Hydroxychloroquine drugs from their revised guidelines for the treatment of the infection. “HCQ may be considered for removal from guideline, with recommendation to use with caution only in clinical trial setting,” said the document titled ‘considerations for exclusion of Ivermectin …

Efforts grow to stamp out use of parasite drug for COVID-19
3 years, 4 months ago

Efforts grow to stamp out use of parasite drug for COVID-19

Associated Press  

WASHINGTON — Health experts and medical groups are pushing to stamp out the growing use of a decades-old parasite drug to treat COVID-19, warning that it can cause harmful side effects and that there’s little evidence it helps. This week, the top U.S. professional groups for doctors and pharmacists appealed for an “immediate end” to the drug’s use outside of …

Efforts grow to stamp out use of parasite drug for COVID-19
3 years, 4 months ago

Efforts grow to stamp out use of parasite drug for COVID-19

Associated Press  

WASHINGTON — Health experts and medical groups are pushing to stamp out the growing use of a decades-old parasite drug to treat COVID-19, warning that it can cause harmful side effects and that there’s little evidence it helps. This week, the top U.S. professional groups for doctors and pharmacists appealed for an “immediate end” to the drug’s use outside of …

WHO trial to study potential of 3 anti-malarial drugs against Covid
3 years, 4 months ago

WHO trial to study potential of 3 anti-malarial drugs against Covid

India TV News  

The World Health Organisation has announced a clinical trial to study three antimalarial and anti-inflammatory drugs as potential treatments for patients with Covid. The drugs -- artesunate, imatinib, and infliximab -- were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized Covid-19 patients, the WHO said in a statement. "Finding more effective …

WHO to trial malaria, arthritis drugs as COVID treatments
3 years, 4 months ago

WHO to trial malaria, arthritis drugs as COVID treatments

Al Jazeera  

Three drugs will be added to the UN agency’s global trial to test their efficacy in patients hospitalised with COVID-19. The World Health Organization will test three new drugs as potential treatments for people in hospital with severe COVID-19 as it expands its global trial to 52 countries. Artesunate is currently used for severe malaria, imatinib for certain cancers, and …

WHO Tests 3 Drugs for Treating Coronavirus Infection
3 years, 4 months ago

WHO Tests 3 Drugs for Treating Coronavirus Infection

News 18  

The World Health Organization says it will soon test three drugs used for other diseases to see if they might help patients sickened by the coronavirus. In a statement on Wednesday, the U.N. health agency says the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19. The drugs were …

Remdesivir, HCQ have no antiviral effects: WHO study
3 years, 5 months ago

Remdesivir, HCQ have no antiviral effects: WHO study

India TV News  

Neither Remdesivir, nor hydroxychloroquine helps in recovery of patients hospitalised due to Covid-19, according to a new study conducted by the World Health Organization. The study, led by researchers from the Oslo University Hospital in Norway, found that lack of antiviral effect with Remdesivir and HCQ remained consistent despite patient age, symptom duration, degree of viral load, and presence of …

Vaccines are terrific, but where are the COVID-19 treatments?
3 years, 6 months ago

Vaccines are terrific, but where are the COVID-19 treatments?

LA Times  

Since the early days of the pandemic, we’ve all wanted to know when and how it will end. That research has yielded three authorized vaccines — so far — that are highly effective not just against the original virus but also against its many variants, including the highly transmissible Delta variant. Mehta spoke to The Times about which medicines are …

Anti-malarial drug shows promise in treating Covid-19
3 years, 6 months ago

Anti-malarial drug shows promise in treating Covid-19

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy As governments around the world race to vaccinate their populations, scientists …

US to spend $3.2B on treatments for COVID-19, other viruses
3 years, 6 months ago

US to spend $3.2B on treatments for COVID-19, other viruses

Associated Press  

WASHINGTON — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics. The new program will invest in “accelerating things that are already in progress” for COVID-19 but also would work to come up with treatments for other viruses, said Dr. Anthony Fauci, the nation’s …

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19
3 years, 6 months ago

Biden administration will spend $3.2 billion on development of antiviral pills for treating COVID-19

Daily Mail  

The Biden administration is devoting $3.2 billion to help develop antiviral pills to treat COVID-19, officials said on Thursday. The U.S. government has committed $3.2 billion to help develop antiviral pills to treat COVID-19, officials including Dr Anthony Fauci announced on Thursday Several pills are in development that will be used to minimize symptoms of the virus early on in …

Explained | Why has the Centre revised the protocol for mild COVID-19 cases, and which drugs are not recommended anymore?
3 years, 6 months ago

Explained | Why has the Centre revised the protocol for mild COVID-19 cases, and which drugs are not recommended anymore?

The Hindu  

The story so far: The Union Health Ministry has revised its guidelines for the treatment of COVID-19 patients, particularly for the use of steroids, with doctors reporting a worrying rise in medical complications, such as mucormycosis, due to the abuse of drugs and therapies during treatment. The revised guidelines, issued on May 27, recommend the use of antipyretics for fever …

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab
3 years, 7 months ago

DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab

Firstpost  

Among the drugs and treatment methods that have been removed from the recommendations are Ivermectin, Azithromycin and plasma therapy The Union health ministry has issued guidelines on management of COVID-19 patients, dropping many drugs which have been widely used for treatment until now. While Remdesivir has been granted Emergency Use Authorisation, Tocilizumab has been approved for off-label use only FOLLOW …

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment
3 years, 7 months ago

Govt Issues Advisory for Rational Use of Remdesivir in Covid-19 Treatment

News 18  

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care. To stop the misuse of Remdesivir, the government further recommended that if the drug is to be advised or ordered during odd hours, it should be done …

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure
3 years, 7 months ago

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure

India Today  

Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year, has been found effective in a prophylactic study published in the Journal of The Association of Physicians of India last week. The study said, “hen adjusted for other risk factors, HCQ dose as per government recommendations, 2-3, 4-5, 6 or more weeks …

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium
3 years, 7 months ago

Remdesivir Sale To Be Shifted To Chennai Nehru Indoor Stadium

The Quint  

Chief Minister MK Stalin recently announced that the government will open Remdesivir counters at Madurai, Coimbatore, Trichy and Tirunelveli to address the state-wide shortage of the anti viral drug. In its submissions to the Madras HC, the state government added that it had received 250,000 vials of Remdesivir so far and the minimum requirement in the state was 20,000 vials …

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?
3 years, 7 months ago

Coronavirus Fact Check: Is Remdesivir life saving drug in COVID19, can it be given to patients at home?

India TV News  

During COVID 19 second wave in India, a number of people are seen hunting for oxygen cylinders, ICU beds and many more medical facilities across the country. Know all about it here: According to an infographic video shared by PIB fact check, a verified Twitter account by the government of India to counter misinformation on govt. Meanwhile, India recorded 362,727 …

WHO to restart Covid drug trial with focus on immune responses
3 years, 8 months ago

WHO to restart Covid drug trial with focus on immune responses

India TV News  

The World Health Organization is set to restart an international clinical trial of three existing drugs that can save the lives of people hospitalised with Covid-19. The latest trial will test three drugs that dampen inflammation -- Infliximab, Imatinib and Artesunate. And we need to study drugs that we can deliver in a broad group of countries," added Rottingen, who …

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us
3 years, 8 months ago

What Widespread Recommendation of Remdesivir for COVID-19 and Its Shortage Teach Us

News 18  

Soon after the start of the second wave of COVID-19 pandemic in India, the images of people standing in long queues outside the chemist stores/pharmacies across India, were all over the newspapers. Though clinical trials have not found Remdesivir beneficial in COVID-19 treatment; however, clinicians in India and even the national COVID-19 task force and expert groups in India continue …

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India
3 years, 8 months ago

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India

News 18  

Cipla on Monday announced that it has signed an agreement with Eli Lilly and Company to manufacture baricitinib for COVID-19 treatment. Baricitinib earlier received restricted emergency use approval by y the Central Drugs Standard Control Organization for use in combination with remdesivir for the treatment of hospitalized COVID-19 adult patients requiring supplemental oxygen, Cipla said. “We hope that our donations …

Ex-minister: Bolsonaro eyed decree on chloroquine for COVID
3 years, 8 months ago

Ex-minister: Bolsonaro eyed decree on chloroquine for COVID

Associated Press  

RIO DE JANEIRO — Former Health Minister Luiz Henrique Mandetta said Tuesday that President Jair Bolsonaro had considered issuing a decree officially expanding the use of the anti-malarial drug chloroquine for COVID-19 patients in Brazil, though studies found it ineffective. Mandetta said he was called to a meeting in the presidential palace where he saw a draft of the decree …

Doctors divided over use but scramble for Remdesivir continues
3 years, 8 months ago

Doctors divided over use but scramble for Remdesivir continues

The Hindu  

The scramble for Remdesivir, the anti-viral drug used in COVID-19 management, is increasing by the day even as doctors are divided on its use. Private Hospitals and Nursing Homes Association president H.M. Prasanna said that the helpline set up by the government is of little use. Manjunath, nodal officer for labs and testing in the State’s COVID-19 task force, said …

Throat spray, oral drug for malaria-arthritis effective in reducing spread of Covid-19: Study
3 years, 8 months ago

Throat spray, oral drug for malaria-arthritis effective in reducing spread of Covid-19: Study

Live Mint  

Singapore: An antiseptic throat spray and an oral drug usually prescribed to treat malaria and arthritis have been found to effectively reduce the spread of COVID-19 in high-transmission settings, researchers in Singapore have found, according to a media report on Sunday. The findings were made based on a large-scale clinical trial conducted last May, involving more than 3,000 migrant workers …

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19
3 years, 8 months ago

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19

News 18  

The Indian Council of Medical Research on Tuesday shared some suggestions for rational and safe use of Remdesivir in Covid-19 as the demand for the medicine has increased for treating coronavirus patients especially in Covid-hit states including Maharashtra, Delhi, Karnataka and others. Remdesivir is one of the investigational drugs approved for emergency use in treating hospitalized Covid-19 patients. Suggestion for …

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria
3 years, 8 months ago

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria

News 18  

Amid a steep spike in COVID-19 cases leading to increased demand for medicines for treating coronavirus, top health experts in the government on Monday said anti-viral drug remdesivir is "not a magic bullet" and does not reduce mortality. Addressing the media, AIIMS Director Dr Randeep Guleria said remdesivir should only be given to patients hospitalised with moderate illness, who had …

Amid Covid Spurt, Medicos Advice People To Use Remdesivir Judiciously and Only in a Hospital Setting
3 years, 8 months ago

Amid Covid Spurt, Medicos Advice People To Use Remdesivir Judiciously and Only in a Hospital Setting

News 18  

Amid a fight to acquire Remdesivir for ailing Covid-19 patients, a group of medical experts, professionals, and task-forces have stated that the injection can only be used inside a hospital setting. Maharashtra’s Covid-19 Task Force member Dr. Shashank Joshi took to Twitter to put out a statement saying that Remdesivir is not a ‘life-saving’ drug. The statement also made it …

Yogi Adityanath directs UP health department to urgently acquire Remdesivir injections from Ahmedabad
3 years, 8 months ago

Yogi Adityanath directs UP health department to urgently acquire Remdesivir injections from Ahmedabad

India TV News  

Amid a shortage of Remdesivir in Uttar Pradesh, Chief Minister Yogi Adityanath has directed the state health department to acquire 25,000 injections of Remdesivir from Gujarat's Ahmedabad on an urgent basis. In view of the sudden spike in demand due to the surge in COVID-19 cases, India has also banned the export of Remdesivir and Remdesivir Active Pharmaceutical Ingredients till …

Remdesivir Explained: What is the repurposed Covid-19 drug, why is there a shortage, do you need it?
3 years, 8 months ago

Remdesivir Explained: What is the repurposed Covid-19 drug, why is there a shortage, do you need it?

India Today  

Remdesivir, an injectable anti-viral drug repurposed for Covid-19 treatment, has been flying off the shelves of pharmacies over the last few weeks ever since India began reporting a steep rise in cases of the novel coronavirus. Remdesivir, which was cleared by the country's top drug regulator for restricted use in an emergency situation in June 2020, is being used in …

No evidence of Remdesivir's effectiveness in treating Covid patients: WHO
3 years, 8 months ago

No evidence of Remdesivir's effectiveness in treating Covid patients: WHO

India Today  

Amid the surge in demand for antiviral drug Remdesivir, the World Health Organization has said that there is still no evidence to suggest that the drug is useful in treating hospitalised Covid-19 patients. WHO's Chief Scientist Dr Soumya Swaminathan and its Technical Lead on Covid, Dr Maria Van Kerkhove on Monday told India Today TV that results from five clinical …

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO
3 years, 9 months ago

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO

Firstpost  

The World Health Organization said Wednesday that ivermectin — touted by some on social media as a Covid-19 “miracle cure” — should not be used to treat coronavirus patients. The WHO said: “We recommend not to use ivermectin in patients with Covid-19 except in the context of a clinical trial.” Facebook posts and articles endorsing ivermectin have proliferated in Brazil, …

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO
3 years, 10 months ago

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO

Hindustan Times  

Anti-inflammatory drug hydroxychloroquine should not be used in efforts to prevent infection with Covid-19, according to the World Health Organization. Hydroxychloroquine was touted as a Covid-19 treatment by former President Donald Trump and later deemed ineffective. The WHO’s recommendation is based on evidence from six randomized controlled trials with more than 6,000 participants with or without known exposure to a …

Discover Related